Analysis

Pharmacies Face Key Trial Test As Opioid MDL Intrigue Swirls

By Jeff Overley (May 6, 2022, 11:00 PM EDT) -- America's biggest pharmacy chains are poised for a pivotal trial at the center of multidistrict opioid litigation and the opioid crisis itself, aiming to avert a giant judgment and an enormous expansion of their broader liability in thousands of cases that are suddenly threatening to spiral out of control.

CVS Pharmacy, Walgreens and Walmart, reeling from a jury's conclusion that they contributed to rampant drug abuse in two Ohio counties, will seek to stem their losses at a bench trial starting Tuesday to determine damages in connection with the November verdict.

Here, Law360 shares key details to know about the trial,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!